| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.46 | 0.005 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |